Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitor.

Míreanna Comhchosúla

• In vitro combination of PNU-140690, a human immunodeficiency virus type 1 protease inhibitor, with ritonavir against ritonavir-sensitive and -resistant clinical isolates.
  le: Chong, K T, et al.
  Foilsithe: (1997)
• Susceptibility to PNU-140690 (Tipranavir) of Human Immunodeficiency Virus Type 1 Isolates Derived from Patients with Multidrug Resistance to Other Protease Inhibitors
  le: Rusconi, Stefano, et al.
  Foilsithe: (2000)
• Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease.
  le: DesJarlais, R L, et al.
  Foilsithe: (1990)
• Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease.
  le: Patick, A K, et al.
  Foilsithe: (1996)
• From nonpeptide toward noncarbon protease inhibitors: Metallacarboranes as specific and potent inhibitors of HIV protease
  le: Cígler, Petr, et al.
  Foilsithe: (2005)